In the October 2023 issue of HFM Magazine, Panacea’s Govi Goyal and Fred Stodolak discuss the findings of Panacea’s recent study demonstrating the pitfalls to consider when using machine-readable file data in comparative benchmarking.
Today’s environment necessitates that healthcare CFOs and financial managers can explain, document, and defend the rationale behind their CDM prices. This whitepaper discusses why financial managers who previously had optimized their chargemaster prices or inherited irrational chargemasters should consider a hospital zero-base pricing initiative.
A nationwide analysis of hospitals’ case mix index trends and CC/MCC capture rates since the implementation of ICD-10.